CLINICAL_TRIALS
trial_result
· 2015-03-30
Clinical Trial Update: Tarceva. ICORG 08-41
Summary
A completed clinical trial update for ICORG 08-41 evaluating erlotinib (Tarceva) in non-small cell lung cancer, sponsored by Cancer Trials Ireland.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cancer Trials Ireland | Conditions: Non-small Cell Lung Cancer | Status: COMPLETED